What Happened?
Cincinnati, OH-based Kurome-Therapeutics Appointed Jan Rosenbaum as President, Chief Executive Officer
About the Company
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
About the Person
Jan Rosenbaum is President, Chief Executive Officer at Kurome Therapeutics. Previously, Jan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile